Glaxo gloom dampens FTSE hopes
GlaxoSmithKline shares were back under pressure today after analysts downgraded their ratings in the wake of third quarter results.
While the figures were in line with expectations, City firms including WestLB expressed disappointment at growth for some of the company’s key products.